Anna Bershteyn

NYU Grossman School of Medicine

NIH Rank #1571
  • R01 Holder
  • Top 10% Funded
  • Early Career

NIH Funding · FY2024

Total Funding
$4.1M
Fiscal year 2024
Grants Awarded
7
Active NIH grants
National Rank
#1,571
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $4.1M across 7 grants · National rank #1571.

Top grants by award amount

Anna Bershteyn's NIH grant portfolio, ranked by award amount.

  • 1R01AI179417-01A1R01
    Drug concentration measurement for HIV prevention targets: toward a population-based HIV impact assessment (PHIA) for PrEP
    $891.1K
    award amount
  • 5R01AI174932-02R01
    Rapid Tests for Recent Infection (RTRI) for Precision Public Health in Sub-Saharan Africa: Next-Generation Strategies Amid Changing HIV Epidemiology
    $760.4K
    award amount
  • 5R01MH130238-03R01
    When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
    $711.9K
    award amount
  • 5R01HL169021-02R01
    Leveraging HIV care systems to improve cardiovascular disease prevention in the Kingdom of eSwatini
    $669.6K
    award amount
  • 5R01MH124478-04R01
    Can mental health services break the cycle perpetuating HIV hotspots in sub-Saharan Africa?
    $635.4K
    award amount
  • 3R01HL169021-02S1R01
    Leveraging HIV care systems to improve cardiovascular disease prevention in the Kingdom of eSwatini
    $244.4K
    award amount
  • 3R01HL169021-02S2R01
    Leveraging HIV care systems to improve cardiovascular disease prevention in the Kingdom of eSwatini
    $169.5K
    award amount

Affiliation

Institutions that have administered grants for Anna Bershteyn.

Affiliated with NYU Grossman School of Medicine (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    NYU Grossman School of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1571
  6. 2024
    Entered Top 25% Nationally
    Ranked #1571
  7. 2024
    Entered Top 10% Nationally
    Ranked #1571